T

Tonix Pharmaceuticals Holding Corp
D

TNXP

0.38090
USD
-0.02
(-5.04%)
مغلق
حجم التداول
849,898
الربح لكل سهم
-26
العائد الربحي
-
P/E
-0
حجم السوق
71,188,010
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AKBA
    0.01500
    (0.81%)
    1.86000 USD
    B
    BNGO
    -0.00010
    (-0.05%)
    0.20000 USD
    I
    INO
    0.04500
    (2.52%)
    1.83000 USD
    MRNA
    MRNA
    0.550
    (1.39%)
    40.180 USD
    N
    NVAX
    -0.14000
    (-1.62%)
    8.50000 USD
    V
    VBIV
    0.000000
    (0.00%)
    0.000000 USD
    المزيد
الأخبار
المقالات

العنوان: Tonix Pharmaceuticals Holding Corp.

القطاع: Healthcare
الصناعة: Biotechnology
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targetingCD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.